Abeona Therapeutics hält Präsentationen auf der 2017 RBC Capital Markets Global Healthcare Conference und auf dem 3rd Annual CRISPR Congress - Seite 3

Investorenkontakt: 
Christine Berni-Silverstein 
Vice President, Investor Relations 
Abeona Therapeutics Inc.
[phone]
[e-mail]

Pressekontakt:
Andre'a Lucca
Vice President, Communications & Operations
Abeona Therapeutics Inc.
[phone]
[e-mail]

---

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Abeona Therapeutics Inc via Globenewswire